TRIM22 confers poor prognosis and promotes epithelial-mesenchymal transition through regulation of AKT/GSK3β/β-catenin signaling in non-small cell lung cancer.
about
TRIM22 confers poor prognosis and promotes epithelial-mesenchymal transition through regulation of AKT/GSK3β/β-catenin signaling in non-small cell lung cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
TRIM22 confers poor prognosis ...... in non-small cell lung cancer.
@en
TRIM22 confers poor prognosis ...... in non-small cell lung cancer.
@nl
type
label
TRIM22 confers poor prognosis ...... in non-small cell lung cancer.
@en
TRIM22 confers poor prognosis ...... in non-small cell lung cancer.
@nl
prefLabel
TRIM22 confers poor prognosis ...... in non-small cell lung cancer.
@en
TRIM22 confers poor prognosis ...... in non-small cell lung cancer.
@nl
P2093
P2860
P356
P1433
P1476
TRIM22 confers poor prognosis ...... in non-small cell lung cancer.
@en
P2093
Fang-Fei Yang
Qiu-Yue Wang
Xiao-Ming Zhou
Xue-Jun Hu
P2860
P304
62069-62080
P356
10.18632/ONCOTARGET.18911
P407
P577
2017-07-01T00:00:00Z